EP1389971B1 - Inhalationsmaske für pferde - Google Patents
Inhalationsmaske für pferde Download PDFInfo
- Publication number
- EP1389971B1 EP1389971B1 EP02747164A EP02747164A EP1389971B1 EP 1389971 B1 EP1389971 B1 EP 1389971B1 EP 02747164 A EP02747164 A EP 02747164A EP 02747164 A EP02747164 A EP 02747164A EP 1389971 B1 EP1389971 B1 EP 1389971B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- mask
- inhalation
- inhalation mask
- horse
- channel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000283073 Equus caballus Species 0.000 title claims abstract description 48
- 239000000443 aerosol Substances 0.000 claims abstract description 19
- 230000029058 respiratory gaseous exchange Effects 0.000 claims abstract description 11
- 238000007789 sealing Methods 0.000 claims description 42
- 241000283086 Equidae Species 0.000 claims description 22
- 238000009826 distribution Methods 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 230000008021 deposition Effects 0.000 claims description 5
- 229920003023 plastic Polymers 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 239000004743 Polypropylene Substances 0.000 claims description 2
- 239000000919 ceramic Substances 0.000 claims description 2
- -1 polypropylene Polymers 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 230000002441 reversible effect Effects 0.000 claims 1
- 230000001960 triggered effect Effects 0.000 claims 1
- 238000009827 uniform distribution Methods 0.000 claims 1
- 230000000241 respiratory effect Effects 0.000 abstract description 3
- 238000002664 inhalation therapy Methods 0.000 abstract description 2
- 230000002045 lasting effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 18
- 229940079593 drug Drugs 0.000 description 17
- 239000003570 air Substances 0.000 description 13
- 241000047428 Halter Species 0.000 description 9
- 210000003296 saliva Anatomy 0.000 description 7
- 238000000034 method Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 238000007599 discharging Methods 0.000 description 3
- 238000012377 drug delivery Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000003434 inspiratory effect Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000007788 roughening Methods 0.000 description 3
- 241001023788 Cyttus traversi Species 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 241000282553 Macaca Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 230000026781 habituation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 210000001989 nasopharynx Anatomy 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
- A61D7/04—Devices for anaesthetising animals by gases or vapours; Inhaling devices
Definitions
- the invention relates to the technical field of devices for influencing the Atemaystems of horses by the introduction of substances in the respiratory system.
- the deposition of active ingredients in the lungs by inhalation in comparison to oral administration or injection, leads to an improvement in the effects, a significant dose reduction and avoidance of undesirable side effects. Since horses suffer from severe respiratory problems, effective inhalation therapy can help prevent economic damage.
- Such devices for horses have been known for some time, with different approaches have been followed.
- the US 5,666,948 proposes a device that is somewhat easier to insert into the anterior region of the nose of horses.
- the application of the proposed devices places high demands on the pet owner or user because of their invasiveness.
- a mask with MDI adapter for horses with a source for providing drug aerosols and an aerosol chamber with inlet and outlet valve The actual Advantage of the mask is that the mask is designed adapted to the front part of the horse's head and accordingly no invasive measures for aerosol application are required.
- the proposed mask preferably has an inlet and at least one separate exhalation channel, wherein all channels can be designed with valves, so that exhalation is only possible via the corresponding channel and the inhalation only via the aerosol chamber.
- metered dose inhalers may be used for some medications, where the user must adjust the release of the medication to the inhalation of the horses by pressing a button.
- atria spacers
- the drug release from the spacer must also be adjusted to the inhalation by observing the horse by the user.
- inhalation mask provides the attachment of expiratory and / or inspiratory valves in order to ensure a proper flow of air through the mask.
- valves increase breathing resistance, especially when moisture from the exhaled air has already deposited on them. If such valves are located in the inspiratory limb of the mask between the aerosol generator and the nostrils of the horse, then aerosol particles can precipitate there, which are then no longer available for inhalation. This reduces the efficiency of the system and drug is lost.
- the object of the invention is therefore to provide an inhalation mask for horses, which has a filtration of the expiratory air, an optimized seal the mask on the horse's head and a valve-free air flow and also in handling is economical and user-friendly.
- the oval, conical, bucket-shaped inhalation mask with a horse head opened towards the larger base and a smaller, closed base is according to the invention, wherein it consists of a flexible, but substantially dimensionally stable material, for example plastic and is preferably transparent.
- the inhalation mask On the inner wall, the inhalation mask has a total circumferential, roughened area extending from the equine head edge to at least 10 cm away from the smaller base side.
- the at least one combined inlet / outlet channel of the inhalation mask has the following further features:
- the free flow cross section is as large as possible over the entire channel length, but is at least 4 cm 2 , it is attached at the level of the nostrils, it is firmly or repeatedly releasably connected to the inhalation mask, he has an integrated holder in which inhalant sources can be interchangeable introduced and that on the outside air facing opening of the channel an exchangeable filter element is mounted in or in front of the channel opening, which is releasably fixable via a filter closure with the channel wall and the entire free channel opening covers.
- a filter holder with exchangeable filter membrane or a disposable filter may be mounted in front of the outside air facing opening of the channel, wherein the surface of the filter membrane is preferably formed larger than the cross-sectional area of the inlet / outlet channel to the flow resistance during inhalation and expiration keep as low as possible.
- the filter elements used according to the invention are preferably made of glass fiber ceramic for mechanical filtration or polypropylene for electrostatic filtration of the exhaled air and thus serve to protect the people in the vicinity of the inhaling horse.
- the filter material In addition, it can be adapted and modified to the physico-chemical properties of the active ingredients used and consist, for example, of activated carbon or coated activated carbon.
- two combined inlet / outlet channels are mounted in the inhalation mask at the level of the left and right nostrils, such that the aerosol enriched inhaled air on the way from the aerosol generator to the respective nasal passage as possible undergoes no change in direction to aerosol losses due to impaction avoid.
- the distribution channel according to the invention is characterized in that the free flow cross-section at any point of the split flow path from the inhalation / exhalation channel to the Maaken breathing ports, in the sum of the channels, at least 4 cm 2 and that the partial arms of the distribution channel are formed symmetrically and towards the nostrils end.
- the inhalation sources integrated into the at least one combined inlet / outlet channel create a respirable drug aerosol for the horse and are characterized by having integrated breath control and power supply.
- piezo-nebulizers are proposed as inhalation sources according to the invention, as for example from EP 0 923 957 A1 are known.
- Such inhalant sources can be constructed in very small dimensions, which make it possible according to the inhalation source in the inhalation channels of the mask.
- piezo nebulizers are characterized by a negligible noise during Aersolabgabe, so that the inspiratory process of horses is not disturbed. This nebulizer type offers the possibility of applying the total dose over several minutes, so that calm inhalations are guaranteed.
- the breathing resistance is kept as low as possible for the inhaling horse and avoids aerosol losses due to unwanted deposition on valves.
- the proposed breath control offers the advantage that the user does not have to do the aerosol release himself and coordinate with the horse's breathing pattern, and the drugs are released economically only on inspiration.
- a sensor element for the breath control offer for example, in DE 199 42 675 illustrated flow sensors or in WO 97/48431 described pressure sensors on.
- thermometers offset in the flow direction, for example, the extension of the inhalation source offset or attached to the inhalation source and compared with a Wheatotoneschen bridge to the case of inhalation of the Control belonging evaluation unit to give the signal for generating inhalant.
- the saliva receiving / discharging element attached to the smaller, closed base side is characterized in that it is designed as a bulge at the lower edge of the horse's mouth facing, smaller base side and is repeatedly removable or openable and made of easily cleaned material, e.g. Plastic, preferably transparent plastic for simplified level control is made.
- easily cleaned material e.g. Plastic, preferably transparent plastic for simplified level control is made.
- the sealing ring according to the invention consists of a flexible, reversibly deformable material, preferably of airtight and washable coated foam and is roughened according to the invention in the outer half of the surface.
- the sealing ring according to the invention is designed as a soft tube, which is filled at least a quarter with a jelly-like, yielding substance.
- the mask can be adjusted in a wide range of different horse head sizes.
- the inner diameter of the sealing ring can be designed differently, whereas the outer diameter of the sealing ring remains unchanged adapted to the inner diameter of the inhalation mask.
- the at least two mask-holding elements are externally attached to the inhalation mask, a maximum of 20 cm apart from the edge of the larger, open base side of the mask.
- the fastening elements are designed as a downwardly rounded, open hook towards the smaller base side of the mask, and are located opposite to the side of the inhalation mask.
- At this support elements can be a in its length attach adjustable strap, which runs around the neck of the horse or is designed as the upper part of a horse halter.
- a tether may be attached to each support member and releasably secured to the halter to fix the inhalation mask to the horse's head.
- the mask sealing sock is made of an air-impermeable, rubbery, reversibly stretchable material, is open on both sides and has at one edge over at least two metal-reinforced openings for the passage of the mask support member.
- the mask-sealing sock is circumferentially fixedly connected to the outer wall of the inhalation mask in the area of the larger base side opened towards the horse's head. Due to its rubber-like elasticity, the free end of the sealing stocking forms a smaller opening circumference than the larger base side of the inhalation mask opened towards the horse's head.
- the mask holds due to the wedging on the horse's head.
- the adjustable strap is now attached to them, over which mask and sealing stocking are additionally fixed to the neck of the horse.
- Dichtstrumpfs inhalation mask is inventively created with the following steps:
- Fig. 1 illustrates the principle of attachment of the inhalation mask in a schematic, broken side view of a horse's head with the inhalation mask (1) according to the invention in cross section. Attached to the side and thus not shown here are the inhalation / exhalation channels according to the invention with integrated inhalation source and filter elements, Shown are the saliva receptacle / Ablasaelentent (13) on the front, the mask sealing ring (10), top and bottom mounted mask support members (12) for the circumferential mask-sealing sock (11).
- Particularly advantageous is the roughening of the sealing ring and / or the inner surface of the mask.
- the sealing of the mask from the environment is achieved by the flexible ring and by the stretchable Dichtstrumpf or by the flexible ring and by tightening the lower two parts of the halter.
- the mask is pressed by the tensile forces of the expanded Dichtstrumpfes, in the latter case by the forces of the straps of the horse halter strapped to the head of the horse and thus the sealing ring tightly around the head of the horse.
- This form of pressure is familiar to horses through the use of halters.
- FIG. 2 shows a schematic view of the inhalation mask (1) with the head-side opening of the mask and a mask sealing ring (10) according to the invention in the foreground, and two schematically indicated combined inhalation / exhalation channels (2) with a schematically illustrated inhalation source (7) in FIG right inhalation / exhalation channel.
- the two inhalation / exhalation channels (2) are at the level of the nostrils appropriate.
- the inhalation source (7) is repeatedly detachably connected to the wall of the channel (2b) by a holder (8).
- the source of inhalant is inventively releasably retained, so that an integrated energy and Inhalatmakers is possible.
- the right channel is covered by a filter element (5), which is fixed by the filter retaining ring (6) as an example for both inhalation / exhalation channels.
- Fig. 3 shows a partially broken, schematic representation of the inhalation / exhalation channel (2) and the Inhalatquella (7) of Fig. 2 with holder (8) of the inhalation source.
- FIG. 4 shows a schematic side view of the inlet / exhalation channel from FIG. 2 and FIG. 3 with filter elements (5a, b) and filter retaining ring (6).
- the final fixation of the inhalation source (7, not shown here) in the inhalation / exhalation channel (2) is then accomplished by inserting the filter support ring (5b) with retaining ring (8b), inserting a filter (5a) and e.g. Screwing in the filter retaining ring (6).
- FIG. 4b shows, similar to FIG. 4, a schematic side view of an inhalation / exhalation channel, but here with an inhalation source (7) with integrated breath control attached to the inner wall of the inhalation / exhalation channel (2) and to the channel (2 ) attachable expansion and taper elements (2a, b), which also serve as a filter holder and the flow cross-section in the region of the filter element (5) increase.
- Fig. 5 shows a schematic, broken-away view from above of an inhalation mask according to the invention with only an inhalation / exhalation channel (2) on the top of the mask and a distribution channel (3) in the region of the nostrils.
- the mask-holding elements (12) are mounted laterally in contrast to Fig. 1 and shown as the mask-sealing stocking (11) and the horse-halter (15) in a horizontal cross-section.
- FIG. 6 shows a vertical cross-section through the inhalation mask (1) according to FIG. 5 along the section line AB with mask breathing openings (4), distribution channel (3), inhalation / exhalation channel (2) on top of the mask and inhalation source integrated therein (7). Due to the high tidal volume of horses (up to 50-180 liters / minute), care should be taken in this advantageous embodiment that the one inlet / Ausatemkanal, and the distribution channel is sufficiently large. Here, a free flow cross-section of less than 4 cm 2 is to be avoided. For smaller flow cross sections, the inhalation mask is not accepted by horses.
- FIG. 7 shows a plan view from above of a particularly advantageous embodiment of the inhalation macaque (1) according to the invention, which differs from the preceding embodiments in that the inhalation / exhalation channel (2) with the inhaled source (7) concealed here is located at the front end the mask (1) is mounted and the distribution channel, the inhale / exhalation air laterally from the front end of the mask to the nostrils back or leads away.
- the devices to be monitored, inhalation source and filter are just as within the field of vision of the user as the saliva collecting / discharging element (13).
- the horse less adverse effects / irritation of the field of view.
- Fig. 8 shows the particularly advantageous embodiment of the inhalation mask according to the invention of FIG. 7 in the horizontal Cross-section with the elements attached to the front of the mask.
- Inhalation source (7) inlet / exhale channel (2) and distribution channel (3) leading from front to back to the nostrils.
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Anesthesiology (AREA)
- Public Health (AREA)
- Respiratory Apparatuses And Protective Means (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Particle Formation And Scattering Control In Inkjet Printers (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10125564A DE10125564A1 (de) | 2001-05-25 | 2001-05-25 | Inhalationsmaske für Pferde |
DE10125564 | 2001-05-25 | ||
PCT/DE2002/001874 WO2002094122A2 (de) | 2001-05-25 | 2002-05-23 | Inhalationsmaske für pferde |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1389971A2 EP1389971A2 (de) | 2004-02-25 |
EP1389971B1 true EP1389971B1 (de) | 2007-12-12 |
Family
ID=7686147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02747164A Expired - Lifetime EP1389971B1 (de) | 2001-05-25 | 2002-05-23 | Inhalationsmaske für pferde |
Country Status (7)
Country | Link |
---|---|
US (1) | US7111626B2 (es) |
EP (1) | EP1389971B1 (es) |
AT (1) | ATE380522T1 (es) |
AU (1) | AU2002317671A1 (es) |
DE (2) | DE10125564A1 (es) |
ES (1) | ES2299585T3 (es) |
WO (1) | WO2002094122A2 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10260636A1 (de) * | 2002-12-19 | 2004-07-08 | Nagel, Jochen | Inhalationsvorrichtung für Tiere, insbesondere Pferde zur speziellen Anwendung am bewegten Tier |
DE10322505B4 (de) * | 2003-05-19 | 2009-11-05 | Pari GmbH Spezialisten für effektive Inhalation | Inhalationstherapiemaske und -vorrichtung für Tiere |
DE102005033808A1 (de) * | 2005-07-20 | 2007-01-25 | Helmut Meyer | Inhalationsmaske für Tiere |
WO2008017100A1 (en) * | 2006-08-09 | 2008-02-14 | Compumedics Medical Innovation Pty Ltd | Air filter for a mask assembly |
EP1928026A1 (en) | 2006-11-30 | 2008-06-04 | Toshiba Lighting & Technology Corporation | Illumination device with semiconductor light-emitting elements |
US20110214671A1 (en) * | 2007-10-24 | 2011-09-08 | Pulmovet Aps | Inhaler assembly |
US20090183733A1 (en) * | 2008-01-17 | 2009-07-23 | Deaver Jr Everette Allen | Nebulizer delivery device and system for animals and method of using same |
US20100094417A1 (en) * | 2008-10-15 | 2010-04-15 | Christopher Robert Johnson | Dual Hook Laryngeal Cable Prosthesis (DHLCP) used to correct airflow in the larynx of horses affected with left recurrent laryngeal neuropathy |
EP2298230A1 (en) | 2009-09-21 | 2011-03-23 | Nortev Limited | Inhalation mask for animals |
US8596224B2 (en) * | 2009-11-06 | 2013-12-03 | Wesley M. Taylor | Adjustable muzzle |
CN105101908B (zh) * | 2013-03-06 | 2017-03-29 | 梅利莎·K·霍克-克纳斯 | 热材料雾化系统 |
DE202015003981U1 (de) | 2015-05-27 | 2015-07-01 | Michael Zisser | Kompakter Zerstäuber zur Inhalation von Wirkstoffe für die Anwendung in der Tiermedizin |
US10179220B2 (en) * | 2015-08-06 | 2019-01-15 | Rebecca G. Canaday | Animal respiratory treatment masks and system |
RU202204U1 (ru) * | 2020-07-10 | 2021-02-05 | Федеральное государственное бюджетное образовательное учреждение высшего образования Санкт-Петербургский государственный университет ветеринарной медицины ФГБОУ ВО СПбГУВМ | Дыхательная маска для лошадей |
FR3121835A1 (fr) * | 2021-04-15 | 2022-10-21 | Sixtine GLANNAZ | Dispositif facial pour équidé. |
US11433212B1 (en) * | 2021-10-07 | 2022-09-06 | Health Micro Devices Corporation | Self-contained face mask system with automatic droplet dispenser for humidification |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3915165A (en) | 1974-09-13 | 1975-10-28 | Minnesota Mining & Mfg | Intratracheal injection system for animals |
US4002167A (en) * | 1974-09-13 | 1977-01-11 | Minnesota Mining And Manufacturing Company | Animal gas mask assembly |
US4143658A (en) | 1975-07-21 | 1979-03-13 | Minnesota Mining And Manufacturing Company | Intratracheal injection system for animals |
DE3000518A1 (de) * | 1980-01-09 | 1981-07-16 | Werner 4543 Lienen Kegel | Inhalationsmaske |
CH653244A5 (de) * | 1981-12-22 | 1985-12-31 | Georg Feierabend | Inhalationsgeraet fuer tiere. |
US4953546A (en) * | 1985-07-16 | 1990-09-04 | Transpirator Technologies, Inc. | Method and apparatus for pulmonary and cariovascular conditioning of the young of large animals |
US5062423A (en) | 1990-02-27 | 1991-11-05 | Minnesota Mining And Manufacturing Company | Equine aerosol drug delivery method and apparatus |
SG45171A1 (en) | 1990-03-21 | 1998-01-16 | Boehringer Ingelheim Int | Atomising devices and methods |
US5954049A (en) * | 1991-10-15 | 1999-09-21 | Trudell Medical Limited | Equine mask with MDI adapter |
US5249570A (en) * | 1991-10-28 | 1993-10-05 | Cox Frederick L | Equine/canine hemoglobin-oxygen training mask |
ES2120607T3 (es) | 1993-02-12 | 1998-11-01 | Minnesota Mining & Mfg | Aparato de suministro de aerosol. |
GB2316323B (en) | 1996-06-20 | 1999-09-22 | Aid Medic Ltd | Dispensing system |
JP3513041B2 (ja) | 1999-01-25 | 2004-03-31 | 三菱電機株式会社 | 流量センサ |
-
2001
- 2001-05-25 DE DE10125564A patent/DE10125564A1/de not_active Withdrawn
-
2002
- 2002-05-23 EP EP02747164A patent/EP1389971B1/de not_active Expired - Lifetime
- 2002-05-23 WO PCT/DE2002/001874 patent/WO2002094122A2/de active IP Right Grant
- 2002-05-23 AU AU2002317671A patent/AU2002317671A1/en not_active Abandoned
- 2002-05-23 DE DE50211358T patent/DE50211358D1/de not_active Expired - Lifetime
- 2002-05-23 ES ES02747164T patent/ES2299585T3/es not_active Expired - Lifetime
- 2002-05-23 AT AT02747164T patent/ATE380522T1/de not_active IP Right Cessation
-
2003
- 2003-05-23 US US10/478,380 patent/US7111626B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE50211358D1 (de) | 2008-01-24 |
US20040231672A1 (en) | 2004-11-25 |
EP1389971A2 (de) | 2004-02-25 |
WO2002094122A2 (de) | 2002-11-28 |
ES2299585T3 (es) | 2008-06-01 |
DE10125564A1 (de) | 2002-11-28 |
AU2002317671A1 (en) | 2002-12-03 |
US7111626B2 (en) | 2006-09-26 |
ATE380522T1 (de) | 2007-12-15 |
WO2002094122A3 (de) | 2003-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1389971B1 (de) | Inhalationsmaske für pferde | |
DE19817332C2 (de) | Atemmaske | |
DE69820275T2 (de) | Spontanatmungsgerät | |
DE10322505B4 (de) | Inhalationstherapiemaske und -vorrichtung für Tiere | |
DE60316211T2 (de) | Vorrichtung zur Atmungsunterstützung | |
DE69413387T2 (de) | Aerosol-abgabevorrichtung | |
DE69328158T2 (de) | Atemmaske mit einem Ausatmungsventil | |
DE69512985T2 (de) | Vorrichtung zur Unterstützung der Atmung | |
DE69522744T2 (de) | Katheter zur Abgabe von Medizin in Aerosolform unter Einsatz eines unter Druck stehenden Treibmittelbehälters | |
DE4011873B4 (de) | Hilfsgerät zur Verwendung mit einem Dosier-Aerosolgerät | |
DE3636669C2 (de) | Anordnung zur Zufuhr von Aerosol zu den Luftwegen und/oder Lungen eines Patienten | |
EP1695730B1 (de) | Bauteil für eine Inhalationsvorrichtung und Inhalationsvorrichtung mit diesem Bauteil | |
DE69511102T2 (de) | Wiederbelebungsgerät | |
DE2453490A1 (de) | Leitungssystem eines atemgeraetes | |
DE2331525A1 (de) | Atemgeraet, insbesondere fuer heilzwecke | |
DE3237582A1 (de) | Inhalationsgeraet fuer tiere | |
DE3900183A1 (de) | Atemventil | |
DE202010013691U1 (de) | Luftröhrenschlauchhalter | |
WO2017072363A1 (de) | Atemmaske, und beatmungsanordnung | |
EP3484560B1 (de) | Atemgesteuerte applikation von pulverförmigem aerosol bei der beatmung oder atemunterstützung eines patienten | |
EP1778328A1 (de) | Gasreservoirbeutel, verteilergehäuse, beatmungsmaske sowie beatmungsverfahren | |
DE60026864T2 (de) | Mundstück für eine Inhalationstherapievorrichtung zum Gebrauch durch von Sauerstoff abhängige Patienten | |
DE10238683A1 (de) | Vorrichtung zur Beeinflussung von Gasflüssen | |
EP0385250A2 (de) | Verfahren und Vorrichtung zur Zuführung von Atemgas | |
WO2018010734A1 (de) | Verneblereinheit mit wechselbarem mundstück |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20031210 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
17Q | First examination report despatched |
Effective date: 20060905 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REF | Corresponds to: |
Ref document number: 50211358 Country of ref document: DE Date of ref document: 20080124 Kind code of ref document: P |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 20080319 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080312 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20071212 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20071212 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2299585 Country of ref document: ES Kind code of ref document: T3 |
|
NLV1 | Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act | ||
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: PA ALDO ROEMPLER Ref country code: CH Ref legal event code: PUE Owner name: JUSTUS-LIEBIG-UNIVERSITAET GIESSEN Free format text: TRANSMIT GESELLSCHAFT FUER TECHNOLOGIETRANSFER MBH#KERKRADER STRASSE 3#35394 GIESSEN (DE) -TRANSFER TO- JUSTUS-LIEBIG-UNIVERSITAET GIESSEN#LUDWIGSTRASSE 23#35090 GIESSEN (DE) |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E |
|
ET | Fr: translation filed | ||
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PCAR Free format text: ALDO ROEMPLER PATENTANWALT;BRENDENWEG 11 POSTFACH 154;9424 RHEINECK (CH) |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080512 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FD4D |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20071212 Ref country code: IE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20071212 |
|
26N | No opposition filed |
Effective date: 20080915 |
|
BERE | Be: lapsed |
Owner name: TRANSMIT G.- FUR TECHNOLOGIETRANSFER MBH Effective date: 20080531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080313 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: TP |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20071212 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080523 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080523 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20071212 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080531 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R082 Ref document number: 50211358 Country of ref document: DE Representative=s name: PATENTANWAELTE OLBRICHT, BUCHHOLD, KEULERTZ PA, DE |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20140521 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20140528 Year of fee payment: 13 Ref country code: CH Payment date: 20140521 Year of fee payment: 13 Ref country code: DE Payment date: 20140521 Year of fee payment: 13 Ref country code: FR Payment date: 20140527 Year of fee payment: 13 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 50211358 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20150523 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150531 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150531 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20160129 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150523 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20151201 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150601 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150524 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20180705 |